Halaven Patient Registry (Metastatic Breast Cancer, MBC)

You may be eligible if

• An eligible patient to be entered into the Registry is defined as:
• 1. Patient with advanced breast cancer.
• 2. Halaven was given or has been treating during the period of 1 Jan 2015 to 31 Dec 2016.
• 3. Halaven was given as single or combination.
• 4. Patient received at least one cycle treatment (a 21-day cycle or 2 doses) of Halaven.
• 5. Patient with at least 80% of the required information of the Registry CRF to be entered. It will be calculated automatically by the Registry system.
• Patient to be selected for the Registry will be based on chorological order of a patient occurred in a study center during the defined period of the Registry, if all other eligibility criteria are met.